Announcement on Progress in Using Idle Raised Funds to Purchase Wealth Management Product
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Progress in Using Idle Raised Funds to Purchase Wealth Management Product
Filed with SSE ·
6ix hasn’t read this filing yet.
Shandong Pharmaceutical Glass Co., Ltd. on 6ix
Earlier from Shandong Pharmaceutical Glass
- Announcement on Early Repurchase, Release of Pledge, and Continued Pledge of Some Shares Held by Controlling Shareholder
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Redemption at Maturity of Some Idle Raised Funds Used to Purchase Financial Products
- Announcement on Attending the 2025 Online Collective Reception Day for Investors of Listed Companies in the Shandong Jurisdiction
- Announcement on Pledge of Some Shares of Controlling Shareholder
Later from Shandong Pharmaceutical Glass
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Progress in Restructuring of Controlling Shareholder
- Notice on Convening the 1st Extraordinary General Meeting in 2025
- Announcement on Convening the 2025 Semi-annual Performance and Cash Dividend Briefing
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
Follow Shandong Pharmaceutical Glass into a list and get an email when it puts out news.
Follow Shandong Pharmaceutical Glass